TERAZOL 7 Drug Patent Profile
✉ Email this page to a colleague
When do Terazol 7 patents expire, and when can generic versions of Terazol 7 launch?
Terazol 7 is a drug marketed by Janssen Pharms and is included in one NDA.
The generic ingredient in TERAZOL 7 is terconazole. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the terconazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Terazol 7
A generic version of TERAZOL 7 was approved as terconazole by SUN PHARMA CANADA on April 6th, 2004.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TERAZOL 7?
- What are the global sales for TERAZOL 7?
- What is Average Wholesale Price for TERAZOL 7?
Summary for TERAZOL 7
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 64 |
| Patent Applications: | 7,644 |
| DailyMed Link: | TERAZOL 7 at DailyMed |
US Patents and Regulatory Information for TERAZOL 7
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Pharms | TERAZOL 7 | terconazole | CREAM;VAGINAL | 019579-001 | Dec 31, 1987 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TERAZOL 7
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Janssen Pharms | TERAZOL 7 | terconazole | CREAM;VAGINAL | 019579-001 | Dec 31, 1987 | 4,358,449 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TERAZOL 7
See the table below for patents covering TERAZOL 7 around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Austria | 366683 | ⤷ Start Trial | |
| Austria | A63678 | ⤷ Start Trial | |
| Australia | 3285078 | ⤷ Start Trial | |
| Australia | 521329 | ⤷ Start Trial | |
| Belgium | 863382 | ⤷ Start Trial | |
| Canada | 1094559 | 1-(1,3 DIOXOLAN-2-YLMETHYL)-1H-IMIDAZOLES ET 1H-1,2,4- TRIAZOLES (1-(1,3-DIOXOLAN-2-YLMETHYL)-1H-IMIDAZOLES AND 1H-1,2, 4-TRIAZOLES) | ⤷ Start Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch